AMBIC was recently funded effective September 1, 2016.
We envision a future where society can harness biological knowledge to efficiently, effectively, reliably, and predictably manufacture protein-based medicines.
Our mission is to develop enabling technologies, knowledge, and design tools and methods that apply and integrate high-throughput and genome-based technologies to fast-track advanced biomanufacturing focused primarily on upstream issues. We are also committed to enlarging the cadre of scientists and engineers capable of advancing biomanufacturing technologies.
AMBIC Launch meeting will be held Wednesday December 7, 2016 (dinner) through Friday December 9, 2016.
If you have any questions, please contact us.